0000899243-17-016675.txt : 20170619
0000899243-17-016675.hdr.sgml : 20170619
20170619160552
ACCESSION NUMBER: 0000899243-17-016675
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170615
FILED AS OF DATE: 20170619
DATE AS OF CHANGE: 20170619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dylan-Hyde Tyler
CENTRAL INDEX KEY: 0001682027
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 17918577
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-15
0
0001674416
CRISPR Therapeutics AG
CRSP
0001682027
Dylan-Hyde Tyler
C/O CRISPR THERAPEUTICS AG
AESCHENVORSTADT 36
4051 BASEL
V8
SWITZERLAND
0
1
0
0
Chief Legal Officer
Stock Option (Right to Buy)
14.43
2017-06-15
4
A
0
65000
0.00
A
2027-06-15
Common Shares
65000
65000
D
This option was granted on June 15, 2017 with respect to 65,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning on July 15, 2017.
/s/ Michael Esposito, attorney-in-fact
2017-06-19